Bristol Myers Squibb Co.: NYSE:BMY market news - Google Finance

Search Images Maps Play YouTube News Gmail Drive More »

Recent Quotes (30 days)

You have no recent quotes

chg | %

Bristol Myers Squibb Co. news

Watch this stock

Showing stories 1 - 5 of about 5

Articles published

All dates (95)
2013
May (1)
April (2)
March (2)
February (2)

BMY 47.40 +0.40 (0.85%)

price chart

Bristol-Myers Squibb Co. Reaffirms FY 2012 EPS Guidance

Reuters Key Development - Apr 26, 2012

AstraZeneca PLC And Bristol-Myers Squibb Company-Forxiga (Dapagliflozin) Receives Positive CHMP Opinion In The European Union For The Treatment Of Type 2 Diabetes

Reuters Key Development - Apr 20, 2012

All-Oral Hepatitis C Virus Treatment with Bristol-Myers Squibb�s Investigational Compounds Daclatasvir And Asunaprevir Achieved Sustained Virologic Response In 77% of Difficult-to-Treat Patients

Reuters Key Development - Apr 19, 2012

Bristol-Myers Squibb Co. Announces Interim Results From Phase II Open-Label Study Of All-Oral Combination Of Investigational Hepatitis C (HCV) Compounds Daclatasvir And GS-7977

Reuters Key Development - Apr 19, 2012

Medivir AB Announces TMC435 in Expanded Clinical Collaboration between Medivir's Partner Janssen R&D Ireland and Bristol-Myers Squibb

Reuters Key Development - Apr 18, 2012